Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator-Reference-Cited by-同舟云学术

Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator

Published:2013-08-29 Issue:10 Volume:15 Page:
ISSN:1523-3804
Container-title:Current Atherosclerosis Reports
language:en
Short-container-title:Curr Atheroscler Rep

Author:

Boffa Michael B.,Koschinsky Marlys L.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11883-013-0360-6.pdf

Reference92 articles.

1. • Dubé JB, Boffa MB, Hegele RA, Koschinsky ML. Lipoprotein(a): more interesting than ever after 50 years. Curr Opin Lipidol. 2012;23:133–40. This is one of a quintet of recent reviews that together comprehensively survey the current landscape of Lp(a) research.

2. • Kronenberg F, Utermann G. Lipoprotein(a): resurrected by genetics. J Intern Med. 2013;273:6–30. This is one of a quintet of recent reviews that together comprehensively survey the current landscape of Lp(a) research.

3. • Taleb A, Witztum JL, Tsimikas S. Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events. Biomark Med. 2011;5:673–94. This is one of a quintet of recent reviews that together comprehensively survey the current landscape of Lp(a) research.

4. • Kolski B, Tsimikas S. Emerging therapeutic agents to lower lipoprotein (a) levels. Curr Opin Lipidol. 2012;23:560–68. This is one of a quintet of recent reviews that together comprehensively survey the current landscape of Lp(a) research.

5. Fless GM, Rolih CA, Scanu AM. Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. J Biol Chem. 1984;259:11470–8.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Therapeutic Approaches for the Management of Elevated Lipoprotein(a): From Traditional Agents to Future Treatment Options;Life;2024-03-12

2. Modern Approaches to Lower Lipoprotein(a) Concentrations and Consequences for Cardiovascular Diseases;Biomedicines;2021-09-20

3. Current Evidence and Future Directions of PCSK9 Inhibition;US Cardiology Review;2021-02-16

4. Prevalence and status of Lipoprotein (a) among Lebanese school children;Scientific Reports;2020-11-26

5. Impact of serum lipoprotein (a) level on coronary plaque progression and cardiovascular events in statin-treated patients with acute coronary syndrome: a yokohama-acs substudy;Journal of Cardiology;2020-07